Anti-Tumor Effects of Mfn2 in Gastric CancerGeer Zhang(Zhejiang Chinese Medical University), Jiren Yu(Hangzhou First People's Hospital)International Journal of Molecular SciencesJune 24, 201310.3390/ijms140713005Cited by 102SaveCiteExport RISWatch citationsRelated PapersPerioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial|The Lancet Oncology|2021|436